Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
MIMEDX GROUP, INC. (MDXG)
Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
07/05/2023 | DOUG RICE | CFO | Grant | Common Stock | 97.2k | $0.00 | $0 | | 07/05/2023 |
07/05/2023 | DOUG RICE | CFO | Grant | Stock Options | 94k | $6.44 | $605.4k | | 07/05/2023 |
06/13/2023 | Newton Todd | Director | Grant | Common Stock | 35.4k | $4.95 | $175k | | 06/13/2023 |
06/13/2023 | LAURENCIN CATO T | Director | Grant | Common Stock | 35.4k | $4.95 | $175k | | 06/13/2023 |
06/13/2023 | BIERMAN JAMES L | Director | Grant | Common Stock | 35.4k | $4.95 | $175k | | 06/13/2023 |
06/13/2023 | BEHRENS M KATHLEEN | Director | Grant | Common Stock | 35.4k | $4.95 | $175k | | 06/13/2023 |
06/13/2023 | GARDNER PHYLLIS | Director | Grant | Common Stock | 35.4k | $4.95 | $175k | | 06/13/2023 |
06/13/2023 | Giuliani Michael J | Director | Grant | Common Stock | 35.4k | $4.95 | $175k | | 06/13/2023 |
06/13/2023 | HAWKINS WILLIAM A | Director | Grant | Common Stock | 35.4k | $4.95 | $175k | | 06/13/2023 |
05/16/2023 | Stein Robert Benjamin | President, Regenerative Med. | Sale | Common Stock | 10.4k | $5.95 | $61.6k | | 05/15/2023 |
05/15/2023 | Stein Robert Benjamin | President, Regenerative Med. | Sale | Common Stock | 3.6k | $6.15 | $22.2k | | 05/15/2023 |
05/10/2023 | Hulse William Frank IV | General Counsel and CAO | Sale | Common Stock | 5.9k | $5.93 | $34.8k | | 05/10/2023 |
05/10/2023 | Stein Robert Benjamin | President, Regenerative Med. | Sale | Common Stock | 5.9k | $5.93 | $34.8k | | 05/10/2023 |
05/10/2023 | Phelan William Lawrence | Chief Accounting Officer | Sale | Common Stock | 1.6k | $5.93 | $9.5k | | 05/10/2023 |
05/10/2023 | Carlson Peter M | CFO | Sale | Common Stock | 6k | $5.93 | $35.4k | | 05/10/2023 |
05/04/2023 | Stein Robert Benjamin | President, Regenerative Med. | Sale | Common Stock | 51.8k | $5.34 | $276.5k | | 05/04/2023 |
05/02/2023 | Phelan William Lawrence | Chief Accounting Officer | Sale | Common Stock | 5.2k | $3.80 | $19.7k | | 05/02/2023 |
03/13/2023 | Stein Robert Benjamin | President, Regenerative Med. | Grant | Common Stock | 135.1k | $4.62 | $624k | | 03/13/2023 |
03/13/2023 | Carlson Peter M | CFO | Grant | Common Stock | 140.5k | $4.62 | $648.9k | | 03/13/2023 |
03/13/2023 | Phelan William Lawrence | Chief Accounting Officer | Grant | Common Stock | 53k | $4.62 | $245k | | 03/13/2023 |
03/13/2023 | Hulse William Frank IV | General Counsel and CAO | Grant | Common Stock | 136.4k | $4.62 | $630k | | 03/13/2023 |
03/07/2023 | Stein Robert Benjamin | President, Regenerative Med. | Sale | Common Stock | 12.4k | $4.24 | $52.4k | | 03/07/2023 |
03/07/2023 | Phelan William Lawrence | Chief Accounting Officer | Sale | Common Stock | 3.4k | $4.24 | $14.4k | | 03/07/2023 |
03/07/2023 | Carlson Peter M | CFO | Sale | Common Stock | 12.1k | $4.24 | $51.2k | | 03/07/2023 |
03/07/2023 | Hulse William Frank IV | General Counsel and CAO | Sale | Common Stock | 11.3k | $4.24 | $48k | | 03/07/2023 |
02/23/2023 | Carlson Peter M | CFO | Sale | Common Stock | 19k | $4.50 | $85.4k | | 02/23/2023 |
02/23/2023 | Hulse William Frank IV | General Counsel and CAO | Sale | Common Stock | 15.6k | $4.53 | $70.5k | | 02/23/2023 |
02/13/2023 | Whitlow Ricci S | COO | Grant | Common Stock | 462.9k | $3.50 | $1.6M | | 02/13/2023 |
12/22/2022 | Carlson Peter M | CFO | Sale | Common Stock | 5k | $2.82 | $14.1k | | 12/22/2022 |
09/15/2022 | Newton Todd | Director | Grant | Common Stock | 200k | $0.00 | $0 | | 09/15/2022 |
09/13/2022 | Stein Robert Benjamin | President, Regenerative Med. | Sale | Common Stock | 8.3k | $3.46 | $28.8k | | 09/12/2022 |
09/12/2022 | Stein Robert Benjamin | President, Regenerative Med. | Sale | Common Stock | 19k | $3.44 | $65.3k | | 09/12/2022 |
08/12/2022 | Stein Robert Benjamin | President, Regenerative Med. | Sale | Common Stock | 8.5k | $4.04 | $34.3k | | 08/12/2022 |
08/09/2022 | Kashyap Rohit | President, WC & Surgical | Sale | Common Stock | 12.3k | $4.21 | $51.9k | | 08/09/2022 |
08/04/2022 | Stein Robert Benjamin | President, Regenerative Med. | Sale | Common Stock | 19.5k | $3.62 | $70.6k | | 08/04/2022 |
|
|